- Home
- ICMB vs IPSC Comparison
ICMB vs IPSC Comparison
Compare ICMB & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICMB
- IPSC
- Stock Information
- Founded
- ICMB 2012
- IPSC 2019
- Country
- ICMB United States
- IPSC United States
- Employees
- ICMB N/A
- IPSC N/A
- Industry
- ICMB Finance: Consumer Services
- IPSC Medicinal Chemicals and Botanical Products
- Sector
- ICMB Finance
- IPSC Health Care
- Exchange
- ICMB Nasdaq
- IPSC Nasdaq
- Market Cap
- ICMB 41.1M
- IPSC 48.2M
- IPO Year
- ICMB N/A
- IPSC 2021
- Fundamental
- Price
- ICMB $2.70
- IPSC $0.53
- Analyst Decision
- ICMB
- IPSC Strong Buy
- Analyst Count
- ICMB 0
- IPSC 5
- Target Price
- ICMB N/A
- IPSC $3.33
- AVG Volume (30 Days)
- ICMB 45.7K
- IPSC 719.1K
- Earning Date
- ICMB 05-13-2025
- IPSC 05-15-2025
- Dividend Yield
- ICMB 17.81%
- IPSC N/A
- EPS Growth
- ICMB N/A
- IPSC N/A
- EPS
- ICMB 0.82
- IPSC N/A
- Revenue
- ICMB $20,996,189.00
- IPSC $114,898,000.00
- Revenue This Year
- ICMB N/A
- IPSC $833.10
- Revenue Next Year
- ICMB N/A
- IPSC N/A
- P/E Ratio
- ICMB $3.27
- IPSC N/A
- Revenue Growth
- ICMB N/A
- IPSC 8286.72
- 52 Week Low
- ICMB $2.46
- IPSC $0.34
- 52 Week High
- ICMB $3.67
- IPSC $3.46
- Technical
- Relative Strength Index (RSI)
- ICMB 38.53
- IPSC 46.73
- Support Level
- ICMB $2.76
- IPSC $0.48
- Resistance Level
- ICMB $3.05
- IPSC $0.59
- Average True Range (ATR)
- ICMB 0.12
- IPSC 0.04
- MACD
- ICMB -0.02
- IPSC -0.00
- Stochastic Oscillator
- ICMB 3.57
- IPSC 34.62
About ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.